BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21436637)

  • 1. Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort.
    Ghassemifar R; Thien CB; Finlayson J; Joske D; Cull GM; Augustson B; Langdon WY
    Pathology; 2011 Apr; 43(3):261-5. PubMed ID: 21436637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.
    Allen C; Hills RK; Lamb K; Evans C; Tinsley S; Sellar R; O'Brien M; Yin JL; Burnett AK; Linch DC; Gale RE
    Leukemia; 2013 Sep; 27(9):1891-901. PubMed ID: 23783394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
    Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
    Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBL mutations do not frequently occur in paediatric acute myeloid leukaemia.
    Coenen EA; Driessen EM; Zwaan CM; Stary J; Baruchel A; de Haas V; de Bont ES; Reinhardt D; Kaspers GJ; Arentsen-Peters ST; Meyer C; Marschalek R; Pieters R; Stam RW; van den Heuvel-Eibrink MM
    Br J Haematol; 2012 Dec; 159(5):577-84. PubMed ID: 23025505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracing the development of acute myeloid leukemia in CBL syndrome.
    Becker H; Yoshida K; Blagitko-Dorfs N; Claus R; Pantic M; Abdelkarim M; Niemöller C; Greil C; Hackanson B; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Döhner K; Schnittger S; Henneke P; Niemeyer CM; Flotho C; Pfeifer D; Ogawa S; Lübbert M
    Blood; 2014 Mar; 123(12):1883-6. PubMed ID: 24493670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].
    Qiao M; Li WY; Sun AN; Chen SN; Liang JY; Ding ZX; Feng YF; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):679-83. PubMed ID: 22339826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core binding factor acute myeloid leukaemia and c-KIT mutations.
    Riera L; Marmont F; Toppino D; Frairia C; Sismondi F; Audisio E; Di Bello C; D'Ardia S; Di Celle PF; Messa E; Inghirami G; Vitolo U; Pich A
    Oncol Rep; 2013 May; 29(5):1867-72. PubMed ID: 23467883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.
    Caligiuri MA; Briesewitz R; Yu J; Wang L; Wei M; Arnoczky KJ; Marburger TB; Wen J; Perrotti D; Bloomfield CD; Whitman SP
    Blood; 2007 Aug; 110(3):1022-4. PubMed ID: 17475912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of SBDS in pediatric acute myeloblastic leukemia.
    Majeed F; Jadko S; Freedman MH; Dror Y
    Pediatr Blood Cancer; 2005 Dec; 45(7):920-4. PubMed ID: 16007594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
    Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
    Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia.
    Oppliger Leibundgut E; Porret NA; Bienz Muggli M; Baumgartner H; Dahlhaus M; Baerlocher GM
    Ann Hematol; 2013 Jan; 92(2):173-7. PubMed ID: 23161387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML.
    Barresi V; Palumbo GA; Musso N; Consoli C; Capizzi C; Meli CR; Romano A; Di Raimondo F; Condorelli DF
    Leuk Res; 2010 Nov; 34(11):1539-42. PubMed ID: 20674974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and experimental characteristics of 20 patients with acute myeloid leukemia with complex variant of t(8; 21)].
    Xia J; Chen SN; Pan JL; Wang QR; Wu YF; Wang Y; Zhang J; Shen J; Xue YQ; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):815-20. PubMed ID: 23998566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT proto-oncogene exon 8 deletions at codon 419 are highly frequent in acute myeloid leukaemia with inv(16) in Indian population.
    Hussain SR; Naqvi H; Mahdi F; Bansal C; Babu SG
    Mol Biotechnol; 2013 Jun; 54(2):461-8. PubMed ID: 22825855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.
    Bacher U; Haferlach C; Schnittger S; Kohlmann A; Kern W; Haferlach T
    Ann Hematol; 2010 Jul; 89(7):643-52. PubMed ID: 20195608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population.
    Ahmad F; Mandava S; Das BR
    Hematol Oncol; 2009 Jun; 27(2):90-7. PubMed ID: 19365794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia.
    Wakita S; Yamaguchi H; Miyake K; Mitamura Y; Kosaka F; Dan K; Inokuchi K
    Leukemia; 2011 Sep; 25(9):1423-32. PubMed ID: 21606963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.
    Du Pisani LA; Shires K
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):106-14. PubMed ID: 26183674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of KIT and FLT3 mutations in acute myeloid leukemia with different subtypes.
    Zaker F; Mohammadzadeh M; Mohammadi M
    Arch Iran Med; 2010 Jan; 13(1):21-5. PubMed ID: 20039765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.